These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24522993)

  • 21. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation.
    Kim PT; Onaca N; Chinnakotla S; Davis GL; Jennings LW; McKenna GJ; Ruiz RM; Levy MF; Goldstein R; Klintmalm GB
    Clin Transplant; 2013; 27(2):311-8. PubMed ID: 23351129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of hepatocellular carcinoma.
    Asham EH; Kaseb A; Ghobrial RM
    Surg Clin North Am; 2013 Dec; 93(6):1423-50. PubMed ID: 24206860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapy.
    Huo TI; Lee PC; Huang YH; Wu JC; Lin HC; Chiang JH; Lee SD
    J Clin Gastroenterol; 2006 Jul; 40(6):543-50. PubMed ID: 16825938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimodal treatment of hepatocellular carcinoma.
    Graf D; Vallböhmer D; Knoefel WT; Kröpil P; Antoch G; Sagir A; Häussinger D
    Eur J Intern Med; 2014 Jun; 25(5):430-7. PubMed ID: 24666568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of HCC.
    de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
    J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.
    Cescon M; Cucchetti A; Ravaioli M; Pinna AD
    J Hepatol; 2013 Mar; 58(3):609-18. PubMed ID: 23041304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy.
    Huo TI; Huang YH; Su CW; Lin HC; Chiang JH; Chiou YY; Huo SC; Lee PC; Lee SD
    Clin Transplant; 2008; 22(4):469-75. PubMed ID: 18318736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
    Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I
    Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
    J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
    Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R
    Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.
    Dahiya D; Wu TJ; Lee CF; Chan KM; Lee WC; Chen MF
    Surgery; 2010 May; 147(5):676-85. PubMed ID: 20004441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
    Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
    Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hepatocellular carcinoma.
    Blum HE
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection.
    Tashiro H; Aikata H; Waki K; Amano H; Oshita A; Kobayashi T; Tanimoto Y; Kuroda S; Tazawa H; Chayama K; Asahara T; Ohdan H
    J Surg Oncol; 2011 Jul; 104(1):3-9. PubMed ID: 21656523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients.
    Bruno R; Puoti M; Sacchi P; Filice C; Carosi G; Filice G
    J Hepatol; 2006; 44(1 Suppl):S146-50. PubMed ID: 16356582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH; Sheppard BC; Schwartz J; Orloff SL
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
    Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies.
    Nouso K; Matsumoto E; Kobayashi Y; Nakamura S; Tanaka H; Osawa T; Ikeda H; Araki Y; Sakaguchi K; Shiratori Y
    J Gastroenterol Hepatol; 2008 Mar; 23(3):453-8. PubMed ID: 17725599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical options for hepatocellular carcinoma: resection and transplantation.
    Olthoff KM
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S98-104. PubMed ID: 9742501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
    J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.